HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis

Launched by NANYANG TECHNOLOGICAL UNIVERSITY · Feb 25, 2021

Keywords

ClinConnect Summary

The HED-Start clinical trial is designed to help patients who have recently started hemodialysis, which is a treatment for end-stage kidney disease. Many patients face challenges and misunderstandings about their treatment that can make adjusting to life on dialysis difficult. This study will explore a group program aimed at improving skills for self-care and enhancing emotional wellbeing for these patients.

To participate, individuals must be at least 21 years old, have been diagnosed with end-stage kidney disease, and have been on hemodialysis for less than 90 days. They should also be comfortable communicating in English or Mandarin. Participants can expect to join group sessions where they will learn valuable skills and receive support from others in similar situations. This trial is currently recruiting participants, and it is important to note that individuals with certain cognitive or psychiatric conditions, or those nearing the end of life, may not be eligible to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed with end-stage kidney disease (ESKD) and established on hemodialysis with the National Kidney Foundation Singapore (NKF) for fewer than 90 days
• • At least 21 years old
• • Proficient in spoken and written English or Mandarin
• Exclusion Criteria:
• • Unwilling or unable to give informed consent or refuse to be randomized
• • Have cognitive impairments or psychiatric conditions that preclude consent
• • Are currently involved in other intervention trials
• • Are failing on dialysis and approaching end of life (supportive/palliative care pathway)